Incanthera
Stage
Series A - II | AliveTotal Raised
$4.66MLast Raised
$1.98M | 8 yrs agoAbout Incanthera
Incanthera is an oncology company with a unique pipeline of technologies that target tumors. The lead cancer therapeutic opportunity is a new chemical entity called ICT2588, which has been designed to attack all forms of solid tumors while leaving healthy tissue unharmed.
Missing: Incanthera's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Incanthera's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Incanthera
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Incanthera is included in 2 Expert Collections, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Incanthera Patents
Incanthera has filed 10 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Experimental cancer drugs
- Monoclonal antibodies
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/1/2018 | 2/9/2021 | Prodrugs, Experimental cancer drugs, Monoclonal antibodies, Transcription factors, Clusters of differentiation | Grant |
Application Date | 3/1/2018 |
|---|---|
Grant Date | 2/9/2021 |
Title | |
Related Topics | Prodrugs, Experimental cancer drugs, Monoclonal antibodies, Transcription factors, Clusters of differentiation |
Status | Grant |
Latest Incanthera News
Dec 7, 2022
Incanthera says its interim results show strong financial control...
Incanthera Frequently Asked Questions (FAQ)
Where is Incanthera's headquarters?
Incanthera's headquarters is located at Suite 315, Liverpool Science Park, Liverpool.
What is Incanthera's latest funding round?
Incanthera's latest funding round is Series A - II.
How much did Incanthera raise?
Incanthera raised a total of $4.66M.
Who are the investors of Incanthera?
Investors of Incanthera include North West Fund for Biomedical, Advent International and University of Bradford.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.